Robert H Barker, Jr

Title: Robert H Barker, Jr: Innovator in Glycosyltransferase Inhibitors and Antibacterial Agents.

Introduction

Robert H Barker, Jr is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address serious medical conditions. With a total of 3 patents to his name, Barker's work has the potential to impact the treatment of various diseases.

Latest Patents

One of Barker's latest patents focuses on UDP glycosyltransferase inhibitors and methods of use. This patent describes a compound of Formula (I) and its pharmaceutically acceptable salts. The invention also details compositions and their application in treating diseases such as Krabbe's Disease (KD) and Metachromatic leukodystrophy (MLD). Another significant patent involves anionic polymers as species-specific antibacterial agents. This invention highlights the discovery that certain anionic polymers exhibit useful antibacterial activity.

Career Highlights

Throughout his career, Robert H Barker, Jr has worked with prominent organizations, including Genzyme Corporation. His innovative work has contributed to advancements in medical treatments and pharmaceutical applications.

Collaborations

Barker has collaborated with esteemed colleagues such as Eliezer Rapaport and Paul C Zamecnik. These partnerships have further enriched his research and development efforts.

Conclusion

Robert H Barker, Jr is a distinguished inventor whose work in glycosyltransferase inhibitors and antibacterial agents showcases his commitment to improving healthcare. His contributions continue to pave the way for innovative treatments in the medical field.